HIGHLIGHTS
- who: Nicoletta Cordani and colleagues from the School of Medicine and Surgery, Milano-Bicocca University, Monza, Italy have published the research: Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC), in the Journal: (JOURNAL)
- what: The aim of the present preclinical study is to explore the possibility of a cell therapy approach based on the use of MSCs loaded with PTX to treat TNBC-affected patients. The authors focused on the activity of conditioned media released by PTX-primed MSCs. For the analysis of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.